24
Participants
Start Date
April 23, 2018
Primary Completion Date
April 19, 2019
Study Completion Date
April 19, 2019
480 mg Piperaquine phosphate
480 mg Piperaquine is a bis 4-aminoquinoline and was used mainly in China from the 1960's to the 1980's as an antimalarial monotherapy.
640 mg Piperaquine phosphate
640 mg Piperaquine is a bis 4-aminoquinoline and was used mainly in China from the 1960's to the 1980's as an antimalarial monotherapy.
200 mg OZ 439
200 mg OZ439 + α-tocopherol polyethylene glycol 1000 succinate (TPGS) granules for oral suspension
400 mg OZ 439
400 mg OZ439 + α-tocopherol polyethylene glycol 1000 succinate (TPGS) granules for oral suspension
800 mg OZ 439
800 mg OZ439 + α-tocopherol polyethylene glycol 1000 succinate (TPGS) granules for oral suspension
960 mg PQP
960 mg Piperaquine is a bis 4-aminoquinoline and was used mainly in China from the 1960's to the 1980's as an antimalarial monotherapy.
320 mg PQP
320 mg Piperaquine is a bis 4-aminoquinoline and was used mainly in China from the 1960's to the 1980's as an antimalarial monotherapy.
Q-Pharm, Herston
Collaborators (1)
QIMR Berghofer Medical Research Institute
OTHER
Clinical Network Services (CNS) Pty Ltd
INDUSTRY
Q-Pharm Pty Limited
INDUSTRY
Medicines for Malaria Venture
OTHER